Investing.com - Bio-Techne (NASDAQ: TECH) reported second quarter EPS of $0.49, $0.01 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $306.1M versus the consensus estimate of $306.47M.
Bio-Techne's stock price closed at $78.42. It is down -3.08% in the last 3 months and down -6.98% in the last 12 months.
Bio-Techne saw 3 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Bio-Techne's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Techne's Financial Health score is "great performance".
Check out Bio-Techne's recent earnings performance, and Bio-Techne's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar